Safety and efficacy of oral levosimendan in people with amyotrophic lateral sclerosis (the REFALS study): a randomised, double-blind, placebo-controlled phase 3 trial.
Cudkowicz M, Genge A, Maragakis N, Petri S, van den Berg L, Aho VV, Sarapohja T, Kuoppamäki M, Garratt C, Al-Chalabi A; REFALS investigators.. Xia JH, et al.Nat Genet. 1998 Dec;20(4):370-3. doi: 10.1038/3845.Nat Genet. 1998.PMID: 9843210.
.
Item in Clipboard
The SIC protocol: A seven-step strategy to minimize complications potentially related to the insertion of centrally inserted central catheters.
Brescia F, Pittiruti M, Ostroff M, Spencer TR, Dawson RB.Brescia F, et al..